Resources

Clinical Trials

Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM (https://clinicaltrials.gov/ct2/show/NCT01811498),

Gamma Knife Radiation Clinical Outcomes (https://clinicaltrials.gov/ct2/show/NCT01811498),

Mayo Clinic Gamma Knife

De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma.

Shireman JM, Atashi F, Lee G, Ali ES, Saathoff MR, Park CH, Savchuk S, Baisiwala S, Miska J, Lesniak MS, James CD, Stupp R, Kumthekar P, Horbinski CM, Ben-Sahra I, Ahmed AU

Brain. 2021 May; 144(4): 1230-1246.

https://doi.org/10.1093/brain/awab020

PMID: 33855339

A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma.

Kumthekar P, Ko CH, Paunesku T, Dixit K, Sonabend AM, Bloch O, Tate M, Schwartz M, Zuckerman L, Lezon R, Lukas RV, Jovanovic B, McCortney K, Colman H, Chen S, Lai B, Antipova O, Deng J, Li L, Tommasini-Ghelfi S, Hurley LA, Unruh D, Sharma NV, Kandpal M, Kouri FM, Davuluri RV, Brat DJ, Muzzio M, Glass M, Vijayakumar V, Heidel J, Giles FJ, Adams AK, James CD, Woloschak GE, Horbinski C, Stegh AH

Sci Transl Med. 2021 Mar; 13(584):

https://doi.org/10.1126/scitranslmed.abb3945

PMID: 33692132

Immunotherapy Frontiers: https://brainsforthecure.org/immunotherapy-frontiers-for-brain-tumors/

What is Oligodendroglioma-Cleveland Clinic

Gliomas and Treatments- John Hopkins

Anaplastic Oligodendroglioma- A study by NCBI

Articles:
New York Post (9/20), 5ALA Imaging Dye,
What is the Blood Brain Barrier? (article resource Brains for the Cure),

UNC School of Medicine-Optune Device, Optune–Clinical Study Results,

Gamma Knife Fact Sheet–Yale University,

Novocure chief scientist explains how company’s electronic headgear offers hope to brain tumor patients (article resource Brains for the Cure),

The Power of Positive Thinking–Johns Hopkins ,